CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mort...
Phase 2, Phase 3
San Antonio, Texas, United States and 22 other locations
in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...
Phase 3
San Antonio, Texas, United States and 205 other locations
alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...
Phase 3
San Antonio, Texas, United States and 153 other locations
The primary objective of this study is to compare the efficacy of ABP 234 with the pembrolizumab reference product (Keytruda®).
Phase 3
San Antonio, Texas, United States and 14 other locations
with osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC)....
Phase 1, Phase 2
San Antonio, Texas, United States and 30 other locations
A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with ...
Phase 1
San Antonio, Texas, United States and 22 other locations
The main purpose of the study is to evaluate the safety of GDC-1971 in combination with either osimertinib or cetuximab. The study consists of a dose...
Phase 1
San Antonio, Texas, United States and 14 other locations
pembrolizumab alone in participants with advanced or metastatic non-small cell lung cancer (NSCLC)....
Phase 3
San Antonio, Texas, United States and 230 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell...
Phase 1
San Antonio, Texas, United States and 27 other locations
status as determined by Version 8 of the American Joint Committee on Cancer/Union for International Cancer Control NSCLC staging sy...
Phase 3
San Antonio, Texas, United States and 167 other locations
Clinical trials
Research sites
Resources
Legal